Posttranslational Modifications of p62/SQSTM1 in Health and Disease
MedComm · 2026-10 · 7 (10)
DOI: 10.1002/mco2.70949 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 30.09.2026. Verfasst von Weikai Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology Zhejiang Key Laboratory of Multi-omics Precision Diagnosis and Treatment of Liver Diseases School of Medicine Cancer C…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 204 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province.
Abstract (Originalsprache)
p62/SQSTM1 is a multifunctional adaptor protein that serves as a central hub integrating cellular stress responses, including selective autophagy, antioxidant defense, metabolism, and immune signaling. Its diverse functions are precisely orchestrated by a complex network of posttranslational modifications (PTMs) that dynamically regulate its conformation, protein interactions, stability, and subcellular localization. This review provides a comprehensive overview of the p62 PTMs landscape, encompassing phosphorylation, ubiquitination, acetylation, methylation, and emerging cysteine‐based modifications. We first discuss how these PTMs coordinately maintain cellular homeostasis by fine‐tuning autophagic flux, activating antioxidant programs, coordinating nutrient sensing, preserving genomic stability, and regulating immune responses. We then examine how dysregulation of this PTMs network drives pathogenesis in major diseases including cancer, neurodegenerative disorders, metabolic diseases, and infections, with emphasis on context‐dependent molecular mechanisms. Furthermore, we summarize current preclinical evidence targeting p62 PTMs. Finally, we emphasize the critical need for advanced technologies to decipher PTMs crosstalk and dynamic regulation, coupled with the development of corresponding therapeutic strategies, to advance precision medicine. Understanding the p62 PTMs code offers promising opportunities for developing novel biomarkers and targeted therapies for human diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Oncology Zhejiang Key Laboratory of Multi-omics Precision Diagnosis and Treatment of Liver Diseases School of Medicine Cancer Center of Zhejiang University Sir Run Run Shaw Hospital Zhejiang Univer…
- Department of Pathology School of Medicine Sir Run Run Shaw Hospital Zhejiang University Hangzhou Zhejiang China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Wang, W., Jiang, X., Qiu, R., Wijaya, C. S., Chen, M., Wang, J., Zhu, L., Jin, H., & Feng, L. (2026). Posttranslational Modifications of p62/SQSTM1 in Health and Disease. MedComm, 7(10). https://doi.org/10.1002/mco2.70949
Vancouver
Wang W, Jiang X, Qiu R, Wijaya CS, Chen M, Wang J, et al. Posttranslational Modifications of p62/SQSTM1 in Health and Disease. MedComm. 2026;7(10). doi:10.1002/mco2.70949
BibTeX
@article{Wang2026,
author = {Wang, Weikai and Jiang, Xin and Qiu, Runing and Wijaya, Chandra Sugiarto and Chen, Miaoqin and Wang, Jin and Zhu, Liyuan and Jin, Hongchuan and Feng, Lifeng},
title = {Posttranslational Modifications of p62/SQSTM1 in Health and Disease},
journal = {MedComm},
year = {2026},
volume = {7},
number = {10},
doi = {10.1002/mco2.70949}
}
EUVIMED